The AMH (Anti-Müllerian Hormone) test is a blood test that measures ovarian reserve — how many eggs you have remaining. At Mother Hospitals, Boduppal, we perform AMH testing on any day of the menstrual cycle (no timing needed, no fasting). AMH is the most reliable single marker of ovarian reserve and is essential before IVF. Call 97059 93366 to book.
The most trusted measure of your egg reserve. Test on any day of your cycle. No fasting. Expert interpretation with your personalised fertility plan.
MBBS, DGO, PG Diploma in ART – Kiel University, Germany | 20+ Years Experience | TGMC Reg: 50624
Anti-Müllerian Hormone (AMH) is a protein hormone produced by the granulosa cells — the cells that surround and nourish each developing egg follicle in your ovaries. Unlike other fertility hormones, AMH is not controlled by the monthly cycle. It is produced continuously by the small resting follicles, making it the most stable and convenient ovarian reserve marker available.
AMH does not measure egg quality — it measures egg quantity. Specifically, it reflects the size of the pool of small antral follicles (resting follicles) in the ovaries. Women are born with all the eggs they will ever have — approximately 1–2 million at birth, declining to around 300,000–500,000 at puberty, and continuing to fall with age. AMH tells us how many of those resting follicles remain and how quickly your reserve is declining. The higher the AMH, the larger the pool of available eggs. Very high AMH often indicates PCOS, where many follicles accumulate rather than ovulating normally.
Before AMH, FSH (follicle-stimulating hormone) measured on Day 2–3 of the cycle was the standard test. But FSH has significant limitations: it varies from cycle to cycle, can be normal even with severely diminished reserve, and must be timed to a specific cycle day. AMH is: stable across the menstrual cycle (test any day), stable across multiple cycles (repeatable and comparable), more sensitive than FSH at detecting declining reserve, and predictive of IVF egg yield more accurately than any other single test.
The three main ovarian reserve tests each have strengths. AMH (blood test): Most stable, any-cycle-day testing, best predictor of egg yield — the preferred test for most women. FSH (Day 2–3 blood test): Older marker, must be timed to Day 2–3, less reliable when reserve is borderline. High FSH (above 10 IU/L) is a warning sign but FSH can be falsely normal. AFC (Antral Follicle Count — ultrasound): A transvaginal ultrasound count of small follicles visible in both ovaries — an excellent real-time reserve check. Most fertility specialists combine AMH and AFC together for the most complete picture. At Mother Hospitals, we commonly check both AMH and AFC before designing an IVF stimulation protocol.
AMH declines with age as ovarian reserve naturally diminishes. These values are approximate reference ranges — population averages. Your result must always be interpreted in the context of your age, clinical picture, and fertility goals by a specialist, not just compared to a chart.
These are population averages. Individual variation is significant. A 35-year-old with AMH of 3.0 has above-average reserve for her age. A 28-year-old with AMH of 0.8 has well below expected reserve and needs prompt fertility evaluation. Always interpret in context.
Low AMH (diminished ovarian reserve) means fewer eggs remain in the ovaries than expected for your age. It does not mean zero eggs — it means fewer, and it means time matters. Women with low AMH can and do conceive naturally and through IVF, though IVF egg yield will typically be lower (2–5 eggs). The most important action when AMH is low is to seek specialist advice promptly and not delay. Lifestyle and certain supplements (CoQ10, DHEA where appropriate) may offer modest support. See our dedicated page: Low AMH Treatment Hyderabad.
A normal AMH for your age means your ovarian reserve is appropriate and you are unlikely to face quantity-related fertility problems in the near term. Normal AMH does not guarantee easy conception — other factors (egg quality, fallopian tube patency, uterine health, partner sperm quality) must also be assessed. Normal AMH does not mean you should delay — egg quality declines with age even when quantity remains normal. If you are 35+ and have been trying for 6 months without success, seek evaluation regardless of AMH.
AMH above 3.5–4.0 ng/mL in women aged 30+ is often associated with Polycystic Ovary Syndrome (PCOS). In PCOS, follicles accumulate in the ovaries rather than ovulating regularly — this inflates AMH significantly. High AMH in PCOS does not mean "extra fertile." It means many small follicles are present but not functioning normally. Women with PCOS often have irregular cycles and may struggle to conceive despite high AMH. See: PCOS Treatment Hyderabad.
AMH above 5–6 ng/mL is considered very high and almost always indicates PCOS. During IVF, women with very high AMH are at elevated risk of Ovarian Hyperstimulation Syndrome (OHSS) — an excessive response to fertility drugs that can be dangerous. At Mother Hospitals, we use modified stimulation protocols (lower doses, antagonist protocols, trigger modification, freeze-all strategy) to minimise OHSS risk in women with very high AMH. This is why AMH testing before IVF is so important — it shapes the entire treatment plan.
AMH is the single most important number in personalising your IVF treatment. It determines starting dose of stimulation medication, expected egg yield, OHSS risk, and overall prognosis. Here is how Dr. E. Prashanthi Reddy at Mother Hospitals uses AMH results in IVF planning.
These are expected ranges based on AMH alone. Actual outcomes depend on age, egg quality, uterine factors, and partner sperm quality. AMH predicts quantity, not quality.
This is the question we hear most often from women who have received a low AMH result. The answer is: yes, many women with low AMH do conceive naturally, but it requires an honest understanding of what the number actually means.
The key study to understand is the CARMAL study (2017, published in JAMA), which showed that among women actively trying to conceive naturally, AMH level did NOT predict the probability of conception within 12 months in women aged 30–44 with no infertility diagnosis. However, AMH does predict response to fertility drugs in IVF — a very different situation. The practical message: low AMH should not cause despair in a woman actively trying naturally, but it is a strong signal to seek specialist assessment rather than waiting.
Age is the single strongest determinant of AMH. AMH falls predictably with age as the pool of resting follicles shrinks. This decline accelerates from around age 37–38. Women who want to preserve their options should consider AMH testing in their late 20s and certainly by 32–35 to understand where their reserve stands relative to peers.
Polycystic Ovary Syndrome raises AMH significantly — often 2–4 times above the age-expected range. This is because PCOS causes accumulation of small follicles that all produce AMH. A very high AMH result in a woman with irregular cycles, acne, or excess hair growth strongly suggests PCOS and should prompt a combined AMH + ultrasound evaluation.
Endometriosis — particularly ovarian endometriomas (chocolate cysts) — can significantly reduce AMH. The inflammatory environment around endometriomas damages surrounding ovarian tissue. Ovarian surgery for endometriomas further reduces AMH. Women with endometriosis should have their AMH tested and reassessed before and after any ovarian surgery. Early IVF may be advisable to preserve fertility before reserve declines further.
Smoking is a well-established cause of accelerated ovarian ageing. Women who smoke have AMH levels approximately 10–15% lower than non-smokers of the same age. Smoking also damages egg quality through oxidative stress. Stopping smoking is one of the most impactful lifestyle changes a woman can make for her fertility, and AMH levels do show modest improvement after cessation over 6–12 months.
Any surgery on the ovaries carries a risk of reducing AMH — particularly removal of ovarian cysts, where healthy tissue can accidentally be removed alongside the cyst. Bilateral ovarian drilling (for PCOS) also reduces AMH. If you have had ovarian surgery and are planning a pregnancy, testing your current AMH is important before assuming fertility is unchanged.
Certain chemotherapy drugs — particularly alkylating agents (cyclophosphamide) — and pelvic radiotherapy can significantly and permanently reduce AMH by damaging ovarian follicles. Women about to begin cancer treatment who may want children later should consider egg or embryo freezing before treatment. AMH testing before and after chemotherapy guides the timing of any subsequent fertility treatment.
This is one of the most frequently asked questions — and one where many clinics mislead patients. Here is our honest summary of the current evidence.
The number of follicles in your ovaries is fixed at birth and cannot be increased. No treatment — supplements, diet, injections, or otherwise — can create new eggs. Claims that a treatment "increased AMH" in a small number of patients are almost always explained by natural month-to-month variation in AMH readings (up to 10–15% is normal), measurement differences between labs, or regression to the mean. If a clinic claims their treatment will "boost your AMH," ask for peer-reviewed published evidence and treat the answer with appropriate scepticism.
CoQ10 (Coenzyme Q10): The most studied antioxidant for egg quality. Some evidence it improves mitochondrial function in oocytes, especially in women over 35. 200–600mg/day for 3 months. Does not increase AMH but may improve egg quality per remaining follicle. DHEA (Dehydroepiandrosterone): Some evidence in poor responders for improving egg yield during IVF stimulation. Requires prescription and medical supervision. Not for everyone — can worsen PCOS. Vitamin D: Low Vitamin D is associated with lower AMH in some studies. Correcting deficiency (very common in Indian women) is sensible for overall health and may support ovarian function. Stopping smoking: Most evidence-backed change — reverses some oxidative damage over time.
One of the major advantages of AMH over other fertility hormones is that it can be tested at any point in the menstrual cycle. Unlike FSH and LH which must be measured on Day 2–3, AMH is produced continuously and does not fluctuate significantly across the cycle. This means:
Day 1 or Day 25 — it does not matter. You do not need to wait for a specific cycle day. Book whenever is convenient and come in. This is particularly helpful for women with irregular cycles (PCOS) where "Day 2" may be unpredictable.
You do not need to fast before an AMH test. Come in after breakfast, after lunch — it makes no difference. The only preparation is a routine blood draw (5 ml of blood from a vein in your arm).
The oral contraceptive pill slightly suppresses AMH (by approximately 15–30%). If you are on the pill and want the most accurate reading of your true reserve, testing after 2–3 months off the pill is ideal — but if timing is urgent, testing on the pill is still informative. Your doctor will adjust interpretation accordingly.
The AMH test is a blood test sent to a certified hormonal assay laboratory. Costs vary by lab and collection centre.
Anti-Müllerian Hormone blood test with lab report — any day of cycle, no fasting
AMH blood test + Antral Follicle Count scan + specialist interpretation by Dr. Prashanthi
AMH + AFC + FSH/LH/Oestradiol + Thyroid + Prolactin + Semen Analysis + Consultation
Prices are indicative. Call 97059 93366 for current pricing and to book your appointment.
AMH can predict the approximate timing of menopause with some accuracy, but not precisely enough to give an individual woman a reliable date. Research shows that very low AMH (below 0.2 ng/mL) in women in their late 30s or early 40s is associated with earlier menopause onset — typically within 5 years. However, AMH is not a menopause clock. Many women with low AMH continue to have regular cycles for many more years before reaching menopause. What AMH can tell you is whether your reserve is declining faster than expected for your age — giving you information to make informed reproductive decisions sooner.
Absolutely not. Low AMH means lower ovarian reserve — fewer resting follicles than age-expected — but it does not mean zero fertility. Many women with AMH below 1.0 ng/mL conceive naturally and through IVF. The key differences with low AMH in IVF are: fewer eggs retrieved per cycle, potentially needing more than one cycle to accumulate enough embryos, and needing higher doses of stimulation medication. The most important step after a low AMH result is to see a fertility specialist promptly — not to give up, but to plan strategically.
Testing AMH proactively — before you are actively trying — is increasingly recommended, especially for women over 30 or those planning to delay childbearing. Knowing your AMH allows you to: make informed decisions about when to start trying, consider egg freezing if reserve is lower than expected, and identify conditions like PCOS early. It is a simple blood test that can provide important information. At Mother Hospitals, we offer AMH as part of a pre-conception health check. Call 97059 93366 to book.
There is no universal recommendation. For most women, annual AMH testing from age 30–35 onwards is reasonable if they are monitoring their reserve over time or considering delayed childbearing. For women with already low AMH who are actively trying, retesting every 6 months can help track the rate of decline and time IVF cycles appropriately. For women in active IVF treatment, AMH is typically rechecked before each new stimulation cycle. For women with PCOS being treated (weight loss, medication), AMH can be rechecked 6–12 months later to see if it has normalised.
Yes — the combined oral contraceptive pill (OCP) slightly suppresses AMH by approximately 15–30% due to suppression of follicle activity. This suppression is temporary and reversible — AMH returns to baseline within 2–3 months of stopping the pill. If you are on the OCP and want the most accurate AMH reading of your true ovarian reserve, it is best to test after being off the pill for 2–3 months. However, if time is pressing, testing on the pill is still useful — your doctor will interpret the result knowing it may slightly underestimate true reserve.
No — this is one of the most common and important misconceptions about AMH. AMH measures egg quantity (how many follicles remain), not egg quality (the genetic and chromosomal integrity of individual eggs). A woman can have normal or even high AMH but poor egg quality — this is common in women over 38, where quantity may still be adequate but the proportion of genetically normal eggs declines. Conversely, a woman with low AMH may have excellent egg quality — particularly if she is young (under 35). This is why age remains the most powerful predictor of IVF outcome, even when AMH is good.
Not necessarily. High AMH means more follicles — which is an advantage in IVF (more eggs, more embryos, more chances). But if high AMH is due to PCOS, there are often associated issues: irregular or absent ovulation, hormonal imbalances, and elevated OHSS risk during IVF. Women with PCOS and high AMH may struggle to conceive naturally despite many eggs, because the eggs may not ovulate reliably. So high AMH is a positive finding for IVF quantity, but does not guarantee easy natural conception.
There is no absolute minimum AMH required for IVF — we have performed successful IVF cycles in women with AMH as low as 0.1–0.2 ng/mL. The lower the AMH, the fewer eggs to expect, but success is still possible. What changes with lower AMH is the IVF strategy: higher stimulation doses, more monitoring, possibly multiple collection cycles to accumulate embryos, and realistic expectations about egg yield. Dr. E. Prashanthi Reddy will counsel you honestly about what to expect based on your specific AMH, age, and AFC combined — not on AMH alone. Call 97059 93366 for a personalised assessment.
Dr. E. Prashanthi Reddy · TGMC Reg: 50624 · Any day of cycle · No fasting